The wound care industry faces unprecedented scrutiny as Medicare Part B expenditures for skin substitutes exceeded $1.6 billion in the fourth quarter of 2023 alone. The spending surge has triggered a wave of skin substitute...more
7/18/2025
/ Audits ,
Best Practices ,
Centers for Medicare & Medicaid Services (CMS) ,
Compliance ,
Documentation ,
Enforcement Actions ,
Fraud ,
Health Care Providers ,
Health Insurance ,
Healthcare Fraud ,
Medical Devices ,
Medical Records ,
Medicare ,
Medicare Part B ,
Popular ,
Regulatory Requirements ,
Reporting Requirements
A Texas federal court has temporarily blocked the implementation of the Corporate Transparency Act (CTA) nationwide. The decision, issued by Judge Amos L. Mazzant III of the US District Court for the Eastern District of...more
Prescription drug fraud has long been a focus for government regulators, but it has taken on new significance in the wake of America’s opioid crisis. The U.S. Department of Justice (DOJ), Department of Health and Human...more
3/22/2024
/ Anti-Kickback Statute ,
Civil Investigation Demand ,
DEA ,
Department of Health and Human Services (HHS) ,
False Claims Act (FCA) ,
FBI ,
Fraud ,
Healthcare ,
Medicaid ,
Medicare ,
Medicare Administrative Contractors (MAC) ,
Opioid ,
Pharmaceutical Industry ,
Pharmacies ,
Popular ,
Prescription Drugs ,
Telemedicine ,
TRICARE
Beginning January 1, 2024, most small businesses in the United States will have to report information about the people who own and control the business to the federal government.
This new reporting rule was established by...more
12/28/2023
/ Beneficial Owner ,
CEOs ,
CFOs ,
Corporate Transparency Act ,
Financial Crimes ,
FinCEN ,
Limited Liability Company (LLC) ,
Money Laundering ,
Popular ,
Reporting Requirements ,
Shell Corporations ,
Small Business ,
Smaller Reporting Companies ,
Terrorism Funding ,
U.S. Treasury